Clinical Trial Starts To Test Drug For Cannabis Addiction

Segal Trials, a privately held network of clinical research sites throughout South Florida, announced it will conduct a Phase 2B study to investigate a new drug, AEF0117-202, created by Aelis Farma to treat cannabis addiction. No approved pharmacological treatments exist for people suffering from cannabis addiction, so this randomized, double-blind, parallel group trial has the potential to pave the way toward a major advancement in the world of substance abuse treatment. For the first time, people who overuse marijuana may have access to a pill that can help them kick their habit.

AEF0117-202 is the first clinical . . .